100 Questions & Answers About Biliary Cancer

(7)
100 Questions & Answers About Biliary Cancer image
ISBN-10:

1284025373

ISBN-13:

9781284025378

Edition: 1
Released: Dec 03, 2013
Format: Paperback, 136 pages

Description:

100 Questions & Answers About Biliary Cancer provides authoritative and practical answers to the most common questions asked by patients and their loved ones. Providing both doctor and patient perspectives, this easy-to-read book is a comprehensive guide to the basics of biliary cancer, risk factors and prevention, diagnosis, treatment, survivorship, and life after diagnosis. Written by Dr. Ghassan Abou-Alfa, a board-certified medical oncologist who specializes in primary liver cancer (hepatocellular carcinoma), pancreas, gallbladder, and bile duct tumors, 100 Questions & Answers About Biliary Cancer is an invaluable resource for anyone interested in learning what to expect after being diagnosed with biliary cancer.

Best prices to buy, sell, or rent ISBN 9781284025378




Frequently Asked Questions about 100 Questions & Answers About Biliary Cancer

You can buy the 100 Questions & Answers About Biliary Cancer book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $9.99 on Amazon and is available from 9 sellers at the moment.

If you’re interested in selling back the 100 Questions & Answers About Biliary Cancer book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the 100 Questions & Answers About Biliary Cancer book, the best buyback offer comes from and is $ for the book in good condition.

The 100 Questions & Answers About Biliary Cancer book is in very low demand now as the rank for the book is 8,384,744 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.